Vascular access considerations for extracorporeal photopheresis
Citations Over TimeTop 16% of 2018 papers
Abstract
Extracorporeal photopheresis is an immunomodulatory therapy indicated for patients with cutaneous T-cell lymphoma, graft-versus-host disease, and heart or lung allograft rejection. Whole blood from the patient is drawn into the photopheresis instrument where it is separated into its components. Plasma, red blood cells, and the treated buffy coat are subsequently returned to the patient. Consistent, adequate blood flow is necessary to successfully complete the procedure. Vascular access options for photopheresis include peripheral vein cannulation, tunneled central venous catheters, and subcutaneous ports. Photopheresis is a very safe procedure; however, the complications and impact on the patient's quality of life associated with vascular access devices can be significant.
Related Papers
- → Plasma and buffy coat concentration of 8-methoxypsoralen in patients treated with extracorporeal photopheresis(1998)7 cited
- → Possibilities of biological control of extracorporeal photochemotherapy(2018)1 cited
- [Extracorporeal photopheresis in the therapy of Sézary syndrome].(1993)
- → Linear Relationship Between Lymphocyte Subpopulations Counts in Peripheral Blood and Buffy-Coat during Extracorporeal Photopheresis in Patients with Graft-Versus-Hot-Disease Using an Off-Line System(2014)
- → Linear Relationship Between Lymphocyte Counts in Peripheral Blood and Buffy Coat During Extracorporeal Photopheresis in Patients with Graft-Versus-Host Disease(2012)